The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 01, 2011
Filed:
Feb. 26, 2010
Balwinder Singh Bhatti, Winston-Salem, NC (US);
Scott R. Breining, Winston-Salem, NC (US);
Gregory D. Hawkins, Durham, NC (US);
Anatoly Mazurov, Greensboro, NC (US);
Lan Miao, Advance, NC (US);
Craig Harrison Miller, Winston-Salem, NC (US);
Teresa Y. Phillips, Greensboro, NC (US);
Balwinder Singh Bhatti, Winston-Salem, NC (US);
Scott R. Breining, Winston-Salem, NC (US);
Gregory D. Hawkins, Durham, NC (US);
Anatoly Mazurov, Greensboro, NC (US);
Lan Miao, Advance, NC (US);
Craig Harrison Miller, Winston-Salem, NC (US);
Teresa Y. Phillips, Greensboro, NC (US);
Targacept, Inc., Winston-Salem, NC (US);
Abstract
Patients susceptible to or suffering from disorders, such as central nervous system disorders, which are characterized by an alteration in normal neurotransmitter release, such as dopamine release (e.g., Parkinsonism, Parkinson's Disease, Tourette's Syndrome, attention deficient disorder, or schizophrenia), are treated by administering a compound of Formulas 1 or 2, as described herein. The compounds of Formulas 1 and 2 are also useful for treating pain, and treating drug addiction, nicotine addiction, and/or obesity. The compounds can exist as individual stereoisomers, racemic mixtures, diastereomers and the like.